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Hypertension is a systemic condition with high morbidity and mortality rates worldwide, which poses an increased risk for
cardiovascular diseases. In this study, we demonstrated the antioxidant and vasodilator activity of Ugni molinae Turcz. (Murtilla)
fruit, a berry native to Chile and proposed models to explain its modulatory mechanism in hypotensive response. Murtilla fruits
were cultivated in a germplasm bank and submitted to chemical and biological analyses. The phenolic compounds gallic acid,
Catechin, Quercetin-3-𝛽-D-glucoside, Myricetin, Quercetin, and Kaempferol were identified. Murtilla extract did not generate
toxic effects on human endothelial cells and had significant antioxidant activity against ROS production, lipid peroxidation,
and superoxide anion production. Furthermore, it showed dose-dependent vasodilator activity in aortic rings in the presence
of endothelium, whose hypotensive mechanism is partially mediated by nitric oxide synthase/guanylate cyclase and large-
conductance calcium-dependent potassium channels. Murtilla fruits might potentially have beneficial effects on the management
of cardiovascular diseases.
1. Introduction
Cardiovascular disorders are among the major causes of
morbidity and mortality in developed and emerging coun-
tries and involve a strong public burden on treatment
and therapeutic management [1]. An association between
oxidative stress (OS) and the aetiopathogenesis of several
cardiovascular diseases, including atherosclerosis, ischemia,
stroke and hypertension, has been reported [2]. Oxidative
stress resulting from an increased production of free radicals
and/or failures in the antioxidant system can lead to oxida-
tion of lipoproteins and thus development and progression
of atherogenesis [3, 4], acute thrombotic events [5], and
endothelial dysfunction [6], all contributing to a cardiovas-
cular collapse.
In recent years, a number of epidemiological andpharma-
cological studies have suggested that consumption of fruits
and vegetables is associated with a decreased risk for cardio-
vascular disease [6], inflammation, and cancer [7]. However,
the role of individual micronutrients and phytochemicals
therein is far from being understood. Fruits and vegetables
contain a large variety of biologically active elements such
as ascorbic acid [8], folate [9], potassium, and soluble fibers
[10]. These aspects suggest that their consumption can pos-
itively modify markers of cardiovascular disease, such as
blood pressure and cholesterol [11]. In addition, phenolic
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compounds biologically active, such as flavonols, phenolic
acid, anthocyanins, and procyanidins are found in high
concentrations in several fruits [12].
Berries are considered another rich source of antioxidant
molecules able to decrease blood pressure, increase HDL
levels, and stimulate platelet function [13]. Murtilla or myrtle
(Ugni molinae Turcz.) is a native Chilean species belonging
to theMyrtaceae family rich in phenolic components, mainly
flavonoids [14]. Studies on the chemical composition of
Murtilla leaves and fruits indicate the presence of flavan-
3-oles and a variety of flavonoids (Catechin, Myricetin,
kaempferol, and Quercetin) [15, 16]. In this study, we demon-
strated the antioxidant and vasodilator activity of the aqueous
extract from the fruits of Ugni molinae Turcz. (Murtilla) and
proposed models to explain its modulatory mechanism in
hypotensive response.
2. Materials and Methods
2.1. Chemicals. Acetylcholine, atropine, modified
Tyrode’s Salt Solution, and N𝜔-nitro-L-arginine
methyl ester hydrochloride were acquired from
Sigma-Aldrich Chemical Co. (St. Louis, MO, USA);
NaCl, KCl, CaCl
2
⋅6H
2
O, MgCl
2
⋅6H
2
O, NaHCO
3
,
NaH
2
PO
4
, and C
6
H
12
O
6
⋅H
2
O were purchased from
Merck (Darmstadt, Germany). Phenylephrine was
acquired from AcrosOrganics (Geel, Belgium). The
blockers CNCKAPETALCARRCQQH (apamin),
XFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS
(charybdotoxin), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-
1-one (ODQ), (9S,10R,12R)-2,3,9,10,11,12-hexahydro-10-
methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-
fg:3󸀠,2󸀠,1󸀠-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxy-
lic acid, and methyl ester (KT5823) were obtained from
Tocris Bioscience (Bristol, UK).
2.2. Plant Material and Extraction Procedure. Murtilla fruits
(Ugni molinae Turcz.), genotype 14-4, were cultivated in the
germplasm bank of the experimental station of the Agricul-
tural Research Institute INIA-Carillanca, Puerto Saavedra, La
Araucanı´a, Chile. Freshly harvested fruits collected in April
2012 presented a moisture content of 78.2% (wet basis) and
19.7∘Brix. Six grams of the fruits was ground in a mortar and
transferred to a bottle containing 20mL of prewarmed (30∘C)
distilledwater.Themixturewas shaken in an incubator (GFL-
3032, Germany) at 170 rpm, 30∘C, for 20min and vacuum-
filtered (Whatman #1 filter paper). The aqueous extract
was protected from light and oxygen under refrigeration
and used for determination of total phenolic content and
high-performance liquid chromatography (HPLC) analysis.
For HPLC analysis, the original extract was concentrated
to dryness using a rotary evaporator (Bu¨chi R-210, Ger-
many) at 140 rpm, 30∘C and then redissolved in 5mL of
methanol : formic acid (99 : 1, v/v).
2.3. Chemical Analysis
2.3.1. Determination of Total Phenolic Content. The total
phenolic content was determined using the Folin-Ciocalteu
method as described by [17]. Aqueous Murtilla fruit extract
(40 𝜇L) was mixed with distilled water (3.16mL) in a test
tube and then 200 𝜇L of Folin-Ciocalteu reagent was added.
After 5min at 20∘C, 600𝜇L of 20%Na
2
CO
3
was added to the
reaction mixture, which was maintained at 20∘C for 120min
in darkness. The absorbance was measured at 765 nm using a
spectrophotometer (SpectronicGenesys 5, Sweden), and the
results were expressed as 𝜇g of gallic acid equivalent (GAE)
per mL of aqueous extract.
2.3.2. Identification of Phenolic Compounds byHPLC. Pheno-
lic compoundswere identified using theMerckHitachi High-
Performance Liquid Chromatography system (LaChrom,
Tokyo, Japan) coupled to an L-7100 pump and L-4250 UV-
VIS detector. A 5 𝜇m C-18 RP Inertsil ODS-3 column (GL
Sciences Inc, Tokyo, Japan) with a 250mm × 4.60mm i.d.
was used and maintained at 25∘C. The sample extract was
filtered through a 0.45𝜇mfilter, and 20 𝜇Lwas injected for the
analysis of polyphenols.The identification of compounds was
confirmed both by comparison of their retention time with
pure standards and by coinjection. A linear gradient solvent
system consisting of 1% formic acid (A) and acetonitrile (B)
was used at a flow rate of 1mL/min as follows: 0–2min, 100%
A; 2–15min, 80% A/20% B; 15–20min, 70% A/30% B; 20–
30min, 40% A/60% B; and 30–35min, 100% A. Phenolic
compounds were detected at 280 nm [17].
2.4. Cytotoxic Effects of the Fruit Extract on HUVEC-C Cells.
Thecytotoxic effects ofMurtilla fruit extract were determined
on Human Umbilical Vein Endothelial Cells (HUVEC)
ATCCCRL-1730. Cells weremaintained inDulbecco’sMod-
ified Eagle’s Medium (DMEM) high glucose (Gibco, Grand
Island, NY) supplemented with 10% Bovine Fetal Serum
(BFS) and 1% antibiotic (penicillin/streptomycin) (Hyclone,
Salt Lake City, UT) at 37∘C, 5% CO
2
. Cell viability upon
treatment with the fruit extract was assessed through the
MTT method described by Mossman [18] with modifica-
tions. Briefly, cells were harvested and seeded onto 96-
well microtiter plates (Thermo Scientific, Rockford, USA)
containing DMEM plus BFS at a density of 5 × 104 cellsmL−1
and allowed to adhere for 24 h. After that, the adhered
cells were exposed to Murtilla extract at concentrations
ranging from 0.001 to 44 𝜇gGAE/mL. After 24 h incubation,
viabilitywas determined by adding 5 𝜇g/mLofMTT solution,
followed by incubation at 37∘C for 2 h. Cells were washed
with HBSS 1x (Hanks’s Buffer Salt Solution, Hyclone, Salt
Lake City, UT), DMSO was added, and the plate was kept at
room temperature for 2 h. Final DMSO concentration did not
affect cell viability. The succinate dehydrogenase activity was
evaluated by color changes and the absorbance wasmeasured
at 514 nmusing a Biotech Synergy-HTmultiscan photometer.
2.5. Antioxidant Assays. The antioxidant activity of Murtilla
fruit extract was determined by the luminescence reac-
tion of luminol [5-amino-2,3-dihydro-1,4-phthalazinedione]
(Sigma); membrane lipid peroxidation using Bodipy C-11
sensor (Invitrogen); and intracellular superoxide anion pro-
duction using dihydroethidium (DHE, Invitrogen), a sensor
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of superoxide anion (O
2
−), using procedures described by the
manufacturers.
2.5.1. Luminol-Chemiluminescence Assay. This method can
measure oxidantmolecules that activate the luminol dye from
a reduced to an oxidized form, usually by using a ferrous
donor catalyst, such as potassium ferricyanide. Briefly, 50,000
cells/mL were incubated with H
2
O
2
(200𝜇M) for 2 h in high
glucose DMEM. Increasing concentrations of extract (0.1 to
44 𝜇gGAE/mL) were added for 30min, followed by addition
of 600𝜇M luminol and incubation for 15min at room
temperature. Luminescence was measured in a luminometer
(Luminoskan, Thermo Scientific) with 1000ms integration.
The luminescence intensity (represented in %) was compared
with that of a control without antioxidant treatment [19].
2.5.2. Membrane Lipid Peroxidation. For the lipid peroxida-
tion assay, 50,000 cells/mL were incubated in DMEM with
100 𝜇M H
2
O
2
as oxidizing agent for 1 hour at 37∘C. The
cells were exposed to increasing concentrations of Murtilla
extract (0.1 to 4.6 𝜇gGAE/mL) for 30min and then washed
with PBS. Bodipy C-11 (1𝜇M) was added to the solution and
the plate was incubated for 15min at 37∘C. The cells were
washed twice and the absorbancewasmeasured inmicroplate
reader (Biotek Synergy HT) using the recommended spectra
(488/585 for oxidized fraction and 488/595 for nonoxidized
fraction, 35% sensibility). All treatments were compared
with their corresponding control. The images were obtained
through confocal microscopy (Olympus Fluoview 1000) [20].
2.5.3. Intracellular Superoxide Anion Production. Dihydroe-
thidium (DHE) was used in the superoxide anion assay. A
total of 50,000 cells/mL were incubated for 24 h in DMEM
medium. Then 100 𝜇M H
2
O
2
and increasing concentrations
of Murtilla extract (0.1 to 4.1𝜇gGAE/mL) were added for
30min. One micromolar of DHE was added per well and the
plate was incubated for 15min at 37∘C and thenwashed twice.
The fluorescence intensity was measured using a microplate
reader under the spectra 488/595, with 35% sensibility. All
treatments were compared with a control and normalized
considering a basal anion production. The corresponding
images were obtained through confocal microscopy (Olym-
pus Fluoview 1000) [21, 22].
2.6. Vasodilator Effects of the Fruit Extract in Aortic Rings
2.6.1. Ethical Considerations. All experiments were per-
formed in accordance with the ethical principles of the
National Institutes of Health (NIH), Bioethics and Biosecu-
rityManual of FONDECYT, after approval by an Institutional
Review Board of Universidad de La Frontera, Chile.
2.6.2. Experimental Design. Three normotensive male rats
(Sprague Dawley) weighing 200 g were used for the vasodila-
tion experiments.The animals were sacrificed and a thoraco-
tomy procedure was performed to extract their aortic tissues.
Dissection was carefully done to extract the connective
tissues without damaging smooth muscle and endothelial
structures. The isolated tissue was maintained in Tyrode
modified solution under constant oxygenation (95% O
2
and
5% CO
2
) at 37∘C [we will name the Tyrode medium and
oxygenation conditions and temperature as TYRO37 hence-
forth]. Assayswithout endothelial tissuewere also performed.
In these cases, the aorta was dissected in rings of 3 to 5mm
approximately and mounted on a silver stem in isolated
organ bath (LSI, Letica Scientific Instrument) in TYRO37
conditions for 10min. The mounted rings were subjected to
1 gf tension and stabilized for 30min.The data weremeasured
and processed on Powerlab version 5.5 (ADinstruments).
The contractile response was stimulated using 60mM
KCl for 10min and serial washes under TYRO37 condi-
tions. In order to identify the integrity of aortic tissues
and endothelium, 0.5𝜇M phenylephrine was applied and
maintained before reaching the contractile plateau, and then
10 𝜇M acetylcholine was added to the solution, evidencing a
nitric oxide- (NO-) dependent vasodilation.The tissues were
washed with TYRO37 and 0.5𝜇M phenylephrine was added
until reaching a plateau. Then different concentrations of
Murtilla (0.001 to 44 𝜇gGAE/mL) were added to the system,
with and without endothelium.
In order to elucidate the mechanisms involved in these
experiments, the effects ofMurtilla extract on the aortic rings
(𝑛 = 8) were evaluated in the presence of selective inhibitors.
So, aortic rings were preincubated for 20min with 1 𝜇M
apamin (selective inhibitor of K+ channel Ca2+-dependent of
low conductance); 100 𝜇M charybdotoxin (specific inhibitor
of K+ channel Ca2+-dependent of high conductance); 2𝜇M
KT5823 (PKG inhibitor); 1 𝜇M L-NAME (eNOS and iNOS
inhibitor); or 5𝜇M ODQ (selective irreversible inhibitor of
guanylate cyclase competitive with NO) and then exposed
to 0.5 𝜇M phenylephrine until reaching the plateau stage.
Finally, different concentrations of Murtilla extract were
added to the system (0.001 to 44 𝜇gGAE/mL), and the effects
were measured. In all assays, the tension was normalized to
a basal level (0% of contraction) and 100% of contraction
induced by phenylephrine.
2.7. Statistical Analysis. The antioxidant assays were per-
formed in quintuplicate of three independent experiments.
In the cardiovascular assays, a total of three rats were used
to obtain the tissues, and experiments were performed in
quadruplicate. To determine the effective concentrations of
the extract in antioxidant and cardiovascular assays, a nonlin-
ear regression model (dose-response) was used on Graphpad
Prism 5.0 (San Diego, CA, USA). Images in this study were
generated by confocal microscopy (Olympus Fluoview 1000)
and processed on Image J software (NIH, USA).
3. Results and Discussion
3.1. Chemical Characterization of Murtilla Fruit Extract. The
total phenolic content in the aqueous extract of Murtilla
was 88.7mg gallic acid equivalent/L, which is lower than
that reported for aqueous Murtilla fruit extracts from three
locations in Chile with diverse climatic conditions [15].
The phenolic compounds identified by HPLC analysis in
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Table 1: Concentration of phenolic compounds identified in the
aqueous fresh extract from the fruits of Ugni molinae Turcz.
(Murtilla), genotype 14-4 INIA, by high-performance liquid chro-
matography.
Compound Retentiontime (min) Concentration (𝜇g/mL)
Gallic acid 7.72 0.059 ± 0.022
Catechin 10.07 2.696 ± 0.690
Quercetin-3-𝛽-D-glucoside 21.18 0.141 ± 0.086
Myricetin 22.68 0.115 ± 0.001
Quercetin 24.02 0.009 ± 0.001
Kaempferol 25.85 0.014 ± 0.008
Murtilla fruit extract were gallic acid, Catechin, Quercetin-
3-𝛽-D-glucoside, Myricetin, Quercetin, and Kaempferol at
different concentrations (Table 1). These compounds have
been commonly found in Murtilla fruit and leaves [15–17,
23] particularly the flavonol Catechin, which was the most
abundant constituent in our sample (2.696𝜇gGAE/mL).
Recent clinical and experimental data demonstrated the
anti-inflammatory potential of green tea Catechins for the
management of cardiovascular diseases [24], particularly
because of their potent antioxidant properties [25]; therefore,
Catechins have been considered valuable chemical markers
for antioxidant activity in naturally occurring agents. Gallic
acid, Myricetin, Quercetin, Quercetin-3-𝛽-D-glucoside, and
Kaempferol were also found in Murtilla fruit extract at con-
centrations ranging from 0.009 to 0.140 𝜇gGAE/mL. Some
of these compounds have been reported in other types of
endemic berries in Chile (Vaccinium corymbosum, Berberis
microphylla, Luma chequen, Luma apiculata, and Amomyrtus
meli), in addition to Ugni molinae Turcz. (Murtilla). The
fruit extracts of these berries were shown to have antioxidant
activity based on their DPPH radical bleaching activity and
ferric reducing antioxidant power (FRAP) and high ORAC
activity [26–28].
3.2. Cytotoxicity on Endothelial Cells and Antioxidant Prop-
erties. The results show that the tested concentrations of
Murtilla extract (0.001 to 44 𝜇gGAE/mL) did not generate
toxic effects on HUVEC-C cells, as there was only 2% death
at the highest concentration of the extract. Staurosporine,
a protein kinase inhibitor, was used as a positive control
and markedly affected cells with dose-dependent effects
(Figure 1).
The antioxidant activity of Murtilla fruit extract upon
extracellular and intracellular oxidative stress was deter-
mined by different methods. The luminol-chemilumines-
cence assay indicated a significant dose-response effect
of the extract against ROS production, with ED
50% of
1.53 ± 0.82 𝜇gGAE/mL in 1 hour. At the concentration of
4.1 𝜇gGAE/mL Murtilla extract inhibited almost 100% of
ROS production (Figure 2(a)). As ROS are considered a
group of destructive molecules produced in the cell through
metabolism of oxygen [29], their inhibition is highly desir-
able.
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Figure 1: Cytotoxic effects of Murtilla fruit extract on HUVEC-
C cells. Analysis of cell viability in endothelial cells incubated
with Murtilla fruit extract (0.001 to 44 𝜇gGAE/mL) (circles) or
staurosporine (square). The assay was performed in quintuplicate
using the MTT colorimetric method. Dose-response curves were
plotted using a nonlinear regression model.
Membrane lipid peroxidation was reduced upon expo-
sure toMurtilla extract, with DE
50% of 0.091±0.4 𝜇gGAE/mL
(Figures 2(b) and 2(b1)–2(b4)). Some studies [30] have shown
that lipid peroxidation is one of the processes associated
with cardiovascular diseases, such as hypertension and arte-
riosclerosis, so the use of nonenzymatic antioxidants (e.g.,
nutritional supplements) could generate a preventive effect
on the endothelium and smooth muscle cells. Our experi-
ments showed that Murtilla extract can reverse such oxida-
tive process. H
2
O
2
by Fenton’s reaction generates hydroxyl
radicals in the presence of metals such as Fe++ playing a
key role in lipid peroxidation, because combination with
unsaturated lips (process of oxidative initiation) generates
lipid oxidation and subsequently propagation of oxidation to
unoxidized unsaturated lipids [31]. Our experiments showed
that Murtilla extract can limit the generation of ROS and
exert protective scavenging effects, in addition to limiting the
propagation of peroxidation in the membrane.
Finally, the cells exposed to Murtilla extract showed
reduced intracellular superoxide anion (O
2
−) production by
the dye DHE with dose-dependent effects (ED
50% of 3.814 ±
0.22 𝜇gGAE/mL), as seen in Figures 2(c) and 2(c1)–2(c4).
Intracellular OS, specifically in relation to the production
of superoxide anion (and other groups), is associated with
proinflammatory processes such as ischemia/reperfusion
injury, diabetes, and obesity [32–34]. When there is an
increase in the amount of H
2
O
2
in the cell, the enzyme
catalase converts H
2
O
2
into water and molecular oxygen
(mostly reactive) until saturation, a cyclical process that
produces superoxide reactivity and leads to the accumulation
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Figure 2: Antioxidant analysis of Murtilla in endothelial cells. (a) Effects of increasing concentrations of Murtilla (0.01–44 𝜇gGAE/mL)
upon ROS production, measured by the chemiluminescent reaction of luminol. (b) Effects of increasing concentrations of Murtilla (0.01–
44 𝜇gGAE/mL) on reduction of lipid peroxidation induced by H
2
O
2
, measured by BODIPY C-11 dye; (b1) control; (b2) 0.01𝜇gGAE/mL;
(b3) 1 𝜇gGAE/mL; and (b4) 44 𝜇gGAE/mL: the oxidized fraction is shown. (c) Effects of increasing concentrations of Murtilla (0.01–
44 𝜇gGAE/mL) on reduction of intracellular superoxide anion (O
2
−) produced by H
2
O
2
, measured by dihydroethidium dye; (c1) control;
(c2) 0.01 𝜇gGAE/mL; (c3) 1 𝜇gGAE/mL; (c4) and 44 𝜇gGAE/mL: the oxidized fraction is shown. All assays were performed in quintuplicate
of three independent experiments, and dose-response curves were plotted using a nonlinear regression model.
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of superoxide anion in important cell compartments, such
as the nucleus, and regulatory biochemical centers. This
process is associated with the loss of endothelial function
and hence with endogenous regulation processes in vascular
tension [35, 36]. Our data indicate that Murtilla extract
can effectively reduce the superoxide anion production at
low concentrations. This process is not yet elucidated for
most nonenzymatic antioxidants, although some molecules
of great importance such as Quercetin, Kaempferol, and
gallic acid have shown a great antioxidant potential. Because
our sample has different molecules it was not possible to
determine themechanism bywhich the transport ismediated
in the membrane.
Altogether, the results show a protective effect of Murtilla
against OS, which is a topic of major interest in current days,
because OS has been associated with the aetiopathogenesis
of several chronic diseases, including arthritis, cancer, dia-
betes, atherosclerosis, ischemia, failures in immunity, and
endocrine functions, among others [2]. In this sense, the
regulation of OS is differentiated, some studies showed
that the berry constituents, Quercetin, Kaempferol, and
pterostilbene, synergistically attenuate theOS by involvement
of the nuclear factor (erythroid-derived 2)-like 2 signaling
pathway (Nrf2). This system Nrf2 regulates antioxidative
stress enzymes and phase II drug metabolizing/detoxifying
enzymes by binding to antioxidant response element (ARE)
(Figure 3). The authors found that the combined treatment
significantly induced ARE and increased the mRNA and
protein expression of Nrf2-regulated genes [37]. Under basal
conditions, Nrf2 is retained in the cytosol by binding to the
cytoskeletal protein Keap1. Upon exposure to oxidative stress
or other ARE activators, Nrf2 is released from Keap1 and
translocates to the nucleus, where it can bind to the ARE,
leading to the expression of antioxidant and phase II enzymes
that protect the cell from oxidative damage [38, 39]. Some
flavonoids as Quercetin (constituent of Murtilla extract)
has been studied for present influence in the mechanism
of modulation of Nrf2 and Glutathione-related enzymes
as glutamylcysteine-synthetase, Glutathione-peroxidase, and
Glutathione-reductase by the p38-MAPK pathway in HepG2
cells [40], while, in in vivo conditions, it was demonstrated
in Sprague-Dawley rats that the administration of Catechin
prior to the administration of Ketoprofen successfully inhib-
ited oxidative damage by upregulatingNrf2 [41]. In our exper-
iment we determine the antioxidant capacity detecting some
important oxidizing agents as hydrogen peroxide and super-
oxide anion focusing on reduce the oxidative stress. This can
conduce different forms to control of oxidative stress byMur-
tilla extract, probably, acting as radical scavenging improving
the antioxidant response, as well as modulating an intrinsi-
cally pathway to stimulate an activation of ARE to increase
the antioxidant enzymes. We propose more experiment to
determine the mechanism of flavonoids to stimulate the Nrf2
pathway and quantify the enzymes implicated in this process,
even more when these compounds are applied altogether.
3.3. Vasodilator Effects in Aortic Rings. The vasodilator prop-
erties of Murtilla extract were tested using aortic rings
with or without endothelial tissue. Murtilla fruit extract
showed dose-dependent vasodilator activity in the presence
of endothelial tissue with ED
50% of 1.69 ± 0.08 𝜇gGAE/mL,
while no vascular activity was observed in the tissue without
endothelium, as seen in Figure 4(a). Selective inhibitors were
used to elucidate possible mechanisms of action of Murtilla
fruit extract. Its vasodilator effects were not blocked in the
presence of a protein kinase G inhibitor (Figure 4(b)) and
small- and large-conductance calcium-dependent potassium
channel (Kca) inhibitors (Figures 4(c) and 4(d), resp.). On the
other hand, vascular reactivity was inhibited in the presence
of eNOS (Figure 4(e)) and guanylate cyclase (Figure 4(f))
blockers.
In recent years, the intake of fruits has been shown to
have an impact on the incidence and markers of cardiovas-
cular diseases [7], as well as their active components. Some
flavonoids as Catechin have been demonstrated as important
antioxidant which can reduce the oxidative stress associated
with endothelial dysfunction which improves antioxidant
defense [42] scavenging ROS and chelating redox-active
transition of metal ions [43] and, besides that, have the abil-
ity to prevent atherosclerosis, hypertension ischemic heart
diseases, and other cardiovascular disorders enhancing the
vascular integrity and regulating the blood pressure [44].
About this, the cardiovascular effect of flavonoids is not new;
for example, the activity of Quercetin and Myricetin has
distinct signaling mechanism; Quercetin induced biphasic
inotropic and lusitropic effect, positive at lower concentra-
tions and negative at higher concentrations, while Myricetin
elicits coronary dilation without affecting contractility and
relaxation [45].
In order to determine whether Murtilla extract had
vasodilator effects, we incubated rat aortic rings previously
contracted with PE and evaluated the tension generated in
the presence of Murtilla extract at increasing concentrations.
The extract produced a dose-dependent decrease in the
tension generated by the aorta. It has been demonstrated
that the regulation of vascular tone depends on nitric oxide
production by endothelial cells [46] and hyperpolarization of
smooth muscle cells via activation of large, intermediate, and
short conductance calcium-dependent potassium channels.
In our model, the elimination of the endothelial cell layer
from the aorta rings reversed the vasorelaxant effect induced
by Murtilla extract (Figure 4(a)). These data suggest that
the vasolidator mechanism seems to be associated with
NO production by endothelial NOS instead of switching
the polarity of smooth muscle cell membrane. To test this
hypothesis, we did the same experiment using an eNOS
selective blocker (L-NAME). We found that, in the presence
of low or high concentrations of Murtilla extract, the eNOS
blocker partially inhibited the effect mediated by the extract
(Figure 4(e)), suggesting that the effect may be related to an
endothelial component and endothelial-dependent smooth
muscle hyperpolarization. NO diffuses from the endothelial
cell into the smooth muscle cell, where it stimulates cGMP
production and activation of PKG. The conversion of GTP
into cGMP and activation of PKG were also blocked in
this study using ODQ and KT5823, respectively. The data
showed that the vasorelaxant effects ofMurtilla were partially
reversed in the presence of ODQ (Figure 4(f)), whereas
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no changes were observed when using PKG inhibitor (Fig-
ure 4(b)).
Another mechanism that has been proposed to explain
vasodilation is endothelium hyperpolarization via opening
calcium-dependent potassium channels (small-conductance
calcium-activated potassium channel, SK; intermediate-
conductance calcium-activated potassium channel, IK; and
large-conductance calcium-activated potassium channel,
LK); the first two are expressed on the endothelium, while
the last one is expressed in muscle cells [47]. The blocking
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Figure 4: Vasodilator effects of Murtilla on isolated aortic rings. (a) Dose-dependent effects of Murtilla fruit extract (0.1 to 44𝜇gGAE/mL)
upon aortic tissues with intact endothelium (black circles) or without endothelium (empty circles). Aortic rings with endothelium were
exposed to a protein kinase G inhibitor ((b) black circles); small-conductance Kca channel blockers ((c) black circles); large-conductance Kca
channels blocker ((d) black circles); nitric oxide synthase inhibitor ((e) black circles); and guanylate cyclase blocker ((f) black circles) for
20 minutes and then treated with 0.1 to 44𝜇gGAE/mL Murtilla extract to induce vasorelaxation. All treatments were compared with their
controls without blockers (white circles). All assays were performed in quintuplicate of three independent experiments, and dose-response
curves were plotted using a nonlinear regression model.
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of SK channels with apamin produced a drop in the tension
generated in the aortic rings beyond the values found in the
presence of increasing doses of Murtilla, suggesting that the
molecular targets of Murtilla extract may be not only the
NO-GCs signaling cascade, but also IK and LK channels.
This was demonstrated by blocking these channels with
charybdotoxin, a LK channel inhibitor; the data showed no
significant differences in % tension when treated either with
the extract or with charybdotoxin (Figure 4(d)).
In summary, the polyphenols found in the extract Mur-
tilla could stimulate the activation of eNOS-NO-GCs path-
way, as the vasodilator effects were partially reversed by L-
NAME and ODQ. However, it also appears to be an effect on
large-conductance calcium-dependent potassium channels
(a proposed model is shown in Figure 5). Thus, the data
suggest a synergistic effect of the compounds present in the
extract leading to decreased tension of the aortic rings.
A study showed that the application of an important
phenol, resveratrol, induces the overexpression of eNOS
and NO in a concentration-dependent manner between 24
and 72 hours in EA cells, while in HUVEC cells these
effects are observed up to 925 hours [48]. Furthermore,
the cardioprotective effects of this phenol were investi-
gated in vivo. Hypertensive rats previously treated with
resveratrol showed decreased oxidative stress, preserved
endothelial function, and amelioration of hypertension, pre-
venting uncoupling of eNOS and stimulating the production
of NO [49]. Additionally, it has been shown that the exposure
of resveratrol (30 𝜇M) toHUVEC-C cells increases reversibly
the amplitude of potassium currents, increasing the opening
time and decreasing the closing time of LK channels [50].
In the same aspect, Quercetin has been reported as effective
vasodilator in isolated pulmonary restoring Kv currents [51]
and demonstrated in hypertensive humans [52].
Altogether, these findings show evidence that the use
of food preparations obtained from fruits and leaves may
have beneficial effects in preventing and possibly treating
the symptoms of cardiovascular diseases. In this study,
we demonstrated that Murtilla fruit extract has significant
antioxidant and vasodilator properties. We also proposed
mechanistic models to explain the antioxidant and hypoten-
sive effects observed.
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